Replies to post #133134 on Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

Comments from CEO 12-10-15 - "I believe that the $2 share price is the only issue standing in our way to uplist. Our existing agreement with Aspire Capital allows us to meet the capital requirements. Important: It is up to Nasdaq's sole discretion if they will allow us to be on Nasdaq."

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119071885